Skip to main content
Clinical Trials/NCT04253717
NCT04253717
Completed
N/A

Effects of a Motor Control Exercise Program on Lumbopelvic Pain Occurrence and Intensity in Pregnant Women With a History of Lumbopelvic Pain: a Study Protocol for a Randomized Controlled Feasibility Trial.

Université du Québec à Trois-Rivières1 site in 1 country32 target enrollmentApril 2, 2021

Overview

Phase
N/A
Intervention
Not specified
Conditions
Lumbopelvic Pain
Sponsor
Université du Québec à Trois-Rivières
Enrollment
32
Locations
1
Primary Endpoint
Adherence rate
Status
Completed
Last Updated
2 years ago

Overview

Brief Summary

This study protocol was designed to establish the feasibility of conducting a motor control exercise program with pregnant women presenting a history of lumbopelvic pain (LBPP) in order to reduce LBPP occurrence or limit its intensity. This randomized controlled trial also aims to preliminary assess the effectiveness of the program. To do so, 40 pregnant women with a history of LBPP will be recruited and randomly allocated to one of 2 groups: control (20 participants) or intervention (20 participants). The control group will receive standard care, including basic information on what to do when suffering from LBPP. The intervention group will participate in a weekly 40-minute group session and two more 40-minute weekly home exercise sessions. The motor control exercise program will be designed to target strengthening of the lumbo-pelvic-hip core muscles in order to improve stabilization and protection of the spine and pelvis. Participants of this group will also receive standard care. Adequate prevention and treatment of LBPP, experienced by women during pregnancy, should help reduce LBPP occurrence or limit its intensity during pregnancy.

Registry
clinicaltrials.gov
Start Date
April 2, 2021
End Date
December 14, 2022
Last Updated
2 years ago
Study Type
Interventional
Study Design
Parallel
Sex
Female

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Martin Descarreaux

Principal investigator

Université du Québec à Trois-Rivières

Eligibility Criteria

Inclusion Criteria

  • Being pregnant of one fetus
  • Being ≤ 20 weeks pregnant
  • Presenting a history of lumbopelvic pain

Exclusion Criteria

  • Inflammatory rheumatic disease
  • Infectious disease
  • Neuromuscular disease
  • Vascular disease
  • Connective tissue disease
  • Severe disabling pain
  • Neurologic signs and symptoms

Outcomes

Primary Outcomes

Adherence rate

Time Frame: Baseline (Post-intervention)

Defined as attendance to ≥75% of group sessions and ≥ 75% completion of home sessions

Acceptability of the intervention

Time Frame: Week 16 (Post-intervention)

Determined based on how the intervention is perceived by pregnant women (assessed using a 5-point Likert scale : higher score mean a better outcome)

Retention rate

Time Frame: Baseline (Post-intervention)

Defined as the completion of follow-up questionnaire by ≥ 80% of women

Safety of the intervention

Time Frame: Week 16 (Post-intervention)

Determined based on the number of adverse events and defined as nature of adverse events

Recruitment rate

Time Frame: Baseline (Pre-intervention)

Defined as the ability to recruit 40 eligible women, willing to participate to the study

Secondary Outcomes

  • Depression(Baseline (Pre-intervention) and week 16 (Post-intervention))
  • Lumbopelvic pain (incidence and frequency)(Week 16 (Post-intervention))
  • Lumbopelvic pain (intensity)(Week 16 (Post-intervention))
  • Functional disability(Baseline (Pre-intervention) and week 16 (Post-intervention))
  • Fear avoidance behaviors(Baseline (Pre-intervention) and week 16 (Post-intervention))
  • Level of anxiety(Baseline (Pre-intervention) and week 16 (Post-intervention))
  • Physical activity levels(Baseline (Pre-intervention) and week 16 (Post-intervention))

Study Sites (1)

Loading locations...

Similar Trials

Motor Control Exercise Program for... | Clinical Trial